ID U-CH10 AC CVCL_1D66 SY UCH10 DR cancercelllines; CVCL_1D66 DR Cosmic; 2663860 DR GEO; GSM1673855 DR GEO; GSM1673856 DR Wikidata; Q54973612 RX PubMed=26183925; RX PubMed=27102572; RX PubMed=28515451; CC Doubling time: 14 days (PubMed=26183925). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=28515451). CC Omics: Transcriptomics; Microarray. CC Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690. ST Source(s): PubMed=26183925; PubMed=27102572 ST Amelogenin: X ST CSF1PO: 10,11 ST D13S317: 9,13 ST D16S539: 11,13 ST D18S51: 13 ST D19S433: 13,15 ST D21S11: 29,31 ST D2S1338: 19 ST D3S1358: 15,16 ST D5S818: 11 ST D7S820: 9,10 (PubMed=26183925) ST D7S820: 10 (PubMed=27102572) ST D8S1179: 8,13 ST FGA: 24 ST Penta D: 9,13 ST Penta E: 18 ST TH01: 8,9 ST TPOX: 11 ST vWA: 16 DI NCIt; C129927; Sacral chordoma DI ORDO; Orphanet_178; Chordoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female AG 75Y CA Cancer cell line DT Created: 08-07-15; Last updated: 10-04-25; Version: 16 // RX PubMed=27102572; DOI=10.1002/path.4729; PMCID=PMC4922416; RA Scheipl, Susanne RA Barnard, Michelle RA Cottone, Lucia RA Jorgensen, Mette RA Drewry, David Harold RA Zuercher, William J. RA Turlais, Fabrice RA Ye, Hong-Tao RA Leite, Ana P. RA Smith, James A. RA Leithner, Andreas RA Moller, Peter RA Bruderlein, Silke RA Guppy, Naomi RA Amary, Fernanda RA Tirabosco, Roberto RA Strauss, Sandra J. RA Pillay, Nischalan RA Flanagan, Adrienne M. RT "EGFR inhibitors identified as a potential treatment for chordoma in a RT focused compound screen."; RL J. Pathol. 239:320-334(2016). // RX PubMed=28515451; DOI=10.1038/s41598-017-02174-5; PMCID=PMC5435709; RA Jager, Daniela RA Barth, Thomas F.E. RA Bruderlein, Silke RA Scheuerle, Angelika RA Rinner, Beate RA von Witzleben, Adrian RA Lechel, Andre RA Meyer, Patrick RA Mayer-Steinacker, Regine RA von Baer, Alexandra RA Schultheiss, Markus RA Wirtz, Christian R. RA Moller, Peter RA Mellert, Kevin RT "HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and RT sacral chordomas."; RL Sci. Rep. 7:2032-2032(2017). // RX PubMed=26183925; DOI=10.1158/0008-5472.CAN-14-3270; RA von Witzleben, Adrian RA Goerttler, Lukas T. RA Marienfeld, Ralf RA Barth, Holger RA Lechel, Andre RA Mellert, Kevin RA Bohm, Michael RA Kornmann, Marko RA Mayer-Steinacker, Regine RA von Baer, Alexandra RA Schultheiss, Markus RA Flanagan, Adrienne M. RA Moller, Peter RA Bruderlein, Silke RA Barth, Thomas F.E. RT "Preclinical characterization of novel chordoma cell systems and their RT targeting by pharmocological inhibitors of the CDK4/6 cell-cycle RT pathway."; RL Cancer Res. 75:3823-3831(2015). //